Availability of new oncology medicines in Europe 2022

This statistic displays the number of oncology medicines approved by the European Medicines Agency (EMA) between 2017 and 2020 which were available to patients in selected European countries as of January 1, 2022. According to the data, Germany had all of the 41 approved oncology medicines available to patients, the highest amount in Europe.

Number of new oncology medicines approved by the EMA available to patients in Europe as of 2022, by country

Characteristic	Number of medicines available
Germany	41
Italy	37
Denmark	36
Switzerland	36
Austria	35
England	35
France	33
Netherlands	33
Sweden	33
Scotland	30
Finland	29
Greece	29
Portugal	29
Belgium	27
Czech	27
Slovenia	26
Norway	25
Spain	25
Cyprus*	23
Ireland	21
Hungary	20
Luxemburg	20
Bulgaria	17
Poland	17
Iceland	13
Croatia*	11
Romania	10
Russia	10
Estonia	9
Slovakia	9
Serbia	8
Turkey	8
Lithuania	7
Latvia	6
Macedonia*	6
Bosnia*	4
Albania*	2
Kazakhstan	2
Malta*	0

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Sources

Use Ask Statista Research Service

Release date

April 2022

More information

Region

Europe

Survey time period

as of January 1, 2022

Supplementary notes

41 oncology products were approved by the European Medicines Agency between 2017 and 2020.
In most countries availability equates to granting of access to the reimbursement list, except in DK, FI, NO, SE some hospital products are not covered by the general reimbursement scheme.
* Country did not complete a full dataset and therefore availability may be unrepresentative.

Citation formats